Behavioral and neurochemical effects of sodium butyrate in an animal model of mania

Behav Pharmacol. 2011 Dec;22(8):766-72. doi: 10.1097/FBP.0b013e32834d0f1b.

Abstract

The present study investigated the effect of the histone deacetylase inhibitor, sodium butyrate (SB), on locomotor behavior and on mitochondrial respiratory-chain complexes activity in the brain of rats subjected to an animal model of mania induced by d-amphetamine (d-AMPH). In the reversal treatment, Wistar rats were first treated with d-AMPH or saline (Sal) for 14 days. Thereafter, between days 8 and 14, rats were administered SB or Sal. In the prevention treatment, rats were treated with SB or Sal for 14 days and received d-AMPH or Sal between days 8 and 14. The d-AMPH treatment increased locomotor behavior in Sal-treated rats under reversion and prevention treatment, and SB reversed and prevented d-AMPH-related hyperactivity. Moreover, d-AMPH decreased the activity of mitochondrial respiratory-chain complexes in Sal-treated rats in the prefrontal cortex, hippocampus, striatum, and amygdala in both experiments, and SB was able to reverse and prevent this impairment. The present study suggests that the mechanism of action of SB involves induction of mitochondrial function in parallel with behavioral changes, reinforcing the need for more studies on histone deacetylase inhibitors as a possible target for new medications for bipolar disorder treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimanic Agents / pharmacology
  • Antimanic Agents / therapeutic use*
  • Behavior, Animal / drug effects
  • Bipolar Disorder / chemically induced
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / metabolism
  • Brain / drug effects*
  • Brain / metabolism
  • Butyric Acid / pharmacology
  • Butyric Acid / therapeutic use*
  • Central Nervous System Stimulants / pharmacology
  • Dextroamphetamine / pharmacology
  • Disease Models, Animal
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Hyperkinesis / chemically induced
  • Hyperkinesis / drug therapy
  • Hyperkinesis / metabolism
  • Male
  • Motor Activity / drug effects*
  • Rats
  • Rats, Wistar

Substances

  • Antimanic Agents
  • Central Nervous System Stimulants
  • Histone Deacetylase Inhibitors
  • Butyric Acid
  • Dextroamphetamine